Your browser doesn't support javascript.
loading
Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility.
van Blokland, Irene V; Lanting, Pauline; Ori, Anil P S; Vonk, Judith M; Warmerdam, Robert C A; Herkert, Johanna C; Boulogne, Floranne; Claringbould, Annique; Lopera-Maya, Esteban A; Bartels, Meike; Hottenga, Jouke-Jan; Ganna, Andrea; Karjalainen, Juha; Hayward, Caroline; Fawns-Ritchie, Chloe; Campbell, Archie; Porteous, David; Cirulli, Elizabeth T; Schiabor Barrett, Kelly M; Riffle, Stephen; Bolze, Alexandre; White, Simon; Tanudjaja, Francisco; Wang, Xueqing; Ramirez, Jimmy M; Lim, Yan Wei; Lu, James T; Washington, Nicole L; de Geus, Eco J C; Deelen, Patrick; Boezen, H Marike; Franke, Lude H.
Afiliação
  • van Blokland IV; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Lanting P; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Ori APS; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Vonk JM; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Warmerdam RCA; Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Herkert JC; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Boulogne F; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Claringbould A; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Lopera-Maya EA; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Bartels M; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Hottenga JJ; Structural Computational Biology unit, EMBL, Heidelberg, Germany.
  • Ganna A; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Karjalainen J; Department of Biological Psychology, FGB, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Hayward C; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Fawns-Ritchie C; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Campbell A; Broad Institute of MIT and Harvard, Cambridge, MA, United States of America.
  • Porteous D; Analytic and Translational Genetics Unit (ATGU), Massachusetts General Hospital, Boston, MA, United States of America.
  • Riffle S; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Bolze A; Department of Psychology, University of Edinburgh, Edinburgh, United Kingdom.
  • White S; Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Tanudjaja F; Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Wang X; Helix OpCo LLC, San Mateo, California, United States of America.
  • Ramirez JM; Helix OpCo LLC, San Mateo, California, United States of America.
  • Lim YW; Helix OpCo LLC, San Mateo, California, United States of America.
  • Lu JT; Helix OpCo LLC, San Mateo, California, United States of America.
  • Washington NL; Helix OpCo LLC, San Mateo, California, United States of America.
  • de Geus EJC; Helix OpCo LLC, San Mateo, California, United States of America.
  • Deelen P; Helix OpCo LLC, San Mateo, California, United States of America.
  • Boezen HM; Helix OpCo LLC, San Mateo, California, United States of America.
  • Franke LH; Helix OpCo LLC, San Mateo, California, United States of America.
PLoS One ; 16(8): e0255402, 2021.
Article em En | MEDLINE | ID: mdl-34379666
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda